Original Research
Published on 14 May 2026
EZH2 blockade reverses doxorubicin resistance by inducing metabolic vulnerability and enhancing DNA damage in breast cancer
in Pharmacology of Anti-Cancer Drugs
- 237 views
Original Research
Published on 14 May 2026
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 14 May 2026
in Microbiotechnology
Original Research
Published on 14 May 2026
in Breast Cancer
Original Research
Published on 14 May 2026
in Clinical Nutrition
Original Research
Published on 14 May 2026
in Occupational Health and Safety
Original Research
Published on 14 May 2026
in Public Mental Health
Original Research
Published on 14 May 2026
in Microbiological Chemistry and Geomicrobiology
Systematic Review
Published on 14 May 2026
in Breast Cancer
Original Research
Published on 14 May 2026
in Disaster and Emergency Medicine
Original Research
Published on 14 May 2026
in Multiple Sclerosis and Neuroimmunology
Review
Published on 14 May 2026
in Digital Impacts
Mini Review
Published on 14 May 2026
in Cardiovascular and Smooth Muscle Pharmacology
Original Research
Published on 14 May 2026
in Marine Ecosystem Ecology
Original Research
Published on 14 May 2026
in Marine Affairs and Policy
Original Research
Published on 14 May 2026
in Plant Nutrition
Original Research
Published on 14 May 2026
in Otology and Neurotology